Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-789]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **Supplementary Information**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal 
                        ( print page 11558)
                        Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on July 20, 2020, Chattem Chemicals 3801 Saint Elmo Avenue, Chattanooga, Tennessee 37409, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleGamma Hydroxybutyric Acid
2010
IMarihuana
7360
ITetrahydrocannabinols
7370
I4-Methoxyamphetamine
7411
IDihydromorphine
9145
INorlevorphanol
9634
IAmphetamine
1100
IIMethamphetamine
1105
IILisdexamfetamine
1205
IIMethylphenidate
1724
IIANPP (4-Anilino-N-phenethyl-4-piperidine)
8333
IIPhenylacetone
8501
IICocaine
9041
IICodeine
9050
IIDihydrocodeine
9120
IIOxycodone
9143
IIHydromorphone
9150
IIHydrocodone
9193
IILevorphanol
9220
IIMeperidine
9230
IIMeperidine intermediate-A
9232
IIMeperidine intermediate-B
9233
IIMeperidine intermediate-C
9234
IIMethadone
9250
IIMethadone intermediate
9254
IIMorphine
9300
IIOripavine
9330
IIThebaine
9333
IIOpium, powdered
9639
IIOpium, granulated
9640
IIOxymorphone
9652
IINoroxymorphone
9668
IIRacemethorphan
9732
IIAlfentanil
9737
IIRemifentanil
9739
IISufentanil
9740
IITapentadol
9780
IIFentanyl
9801
II
 The company plans to manufacturer the listed controlled substances in bulk for distribution and sale to its customers. In reference to drug code 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as a synthetic. No other activities for this drug code are authorized for this registration. William T. McDermott, Assistant Administrator.


[FR Doc. 2021-03836 Filed 2-24-21; 8:45 am] BILLING CODE 4410-09-P